Hospira Patents Covering ‘Precedex Premix’ Found Invalid In Illinois Case

Mealey's (December 20, 2018, 9:21 AM EST) -- CHICAGO — An Illinois federal judge on Dec. 17 concluded that an abbreviated new drug application (ANDA) for dexmedetomidine products by Fresenius Kabi can proceed because two Hospira Inc. patents purportedly...
To view the full article, register now.